z-logo
open-access-imgOpen Access
Torsade de Pointes/QT Prolongation Associated with Antifungal Triazoles: A Pharmacovigilance Study Based on the U.S. FDA Adverse Event Reporting System(FAERS)
Author(s) -
Zicheng Yu,
Xiaolan Liao
Publication year - 2022
Publication title -
journal of pharmacy and pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.497
H-Index - 78
ISSN - 1482-1826
DOI - 10.18433/jpps32867
Subject(s) - pharmacovigilance , adverse event reporting system , medicine , qt interval , prolongation , adverse effect , antifungal , torsades de pointes , fluconazole , database , computer science , dermatology
Torsade de pointes (TdP)/QT prolongation is a fatal adverse event (AE) when using antifungal triazoles. We aimed to compare the AE signals of TdP/QT prolongation and onset time among different drugs of this kind comprehensively.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here